Literature DB >> 26094951

Systemic Hypertension Induced by Harpagophytum procumbens (devil's claw): A Case Report.

Cesare Cuspidi1,2, Carla Sala3, Marijana Tadic4, Guido Grassi1,5, Giuseppe Mancia2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26094951      PMCID： PMC8031842          DOI： 10.1111/jch.12593

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  15 in total

Review 1.  Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature.

Authors:  E Ernst
Journal:  Can J Cardiol       Date:  2003-06       Impact factor: 5.223

Review 2.  The use of glucosamine, devil's claw (Harpagophytum procumbens), and acupuncture as complementary and alternative treatments for osteoarthritis.

Authors:  Marcus Sanders; Oliver Grundmann
Journal:  Altern Med Rev       Date:  2011-09

Review 3.  Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.

Authors:  Isabella Sudano; Andreas J Flammer; Susanne Roas; Frank Enseleit; Georg Noll; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

4.  Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.

Authors:  Tom Hsun-Wei Huang; Van H Tran; Rujee K Duke; Sharon Tan; Sigrun Chrubasik; Basil D Roufogalis; Colin C Duke
Journal:  J Ethnopharmacol       Date:  2005-10-03       Impact factor: 4.360

Review 5.  Adverse effects of herbal medicines: an overview of systematic reviews.

Authors:  Paul Posadzki; Leala K Watson; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-02       Impact factor: 2.659

Review 6.  Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.

Authors:  Sarah Brien; George T Lewith; Gerry McGregor
Journal:  J Altern Complement Med       Date:  2006-12       Impact factor: 2.579

Review 7.  Herbal products that may contribute to hypertension.

Authors:  Jamal Jalili; Ufuk Askeroglu; Brendan Alleyne; Bahman Guyuron
Journal:  Plast Reconstr Surg       Date:  2013-01       Impact factor: 4.730

Review 8.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

Review 9.  Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Authors:  Chaula K Vora; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

10.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844
View more
  3 in total

Review 1.  The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022.

Authors:  Nomagugu Gxaba; Madira Coutlyne Manganyi
Journal:  Molecules       Date:  2022-06-06       Impact factor: 4.927

2.  Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.

Authors:  Kirtan Joshi; Alan Parrish; Elizabeth A Grunz-Borgmann; Mary Gerkovich; William R Folk
Journal:  BMC Complement Med Ther       Date:  2020-01-15

3.  Analysis of Effectiveness of a Supplement Combining Harpagophytum procumbens, Zingiber officinale and Bixa orellana in Healthy Recreational Runners with Self-Reported Knee Pain: A Pilot, Randomized, Triple-Blind, Placebo-Controlled Trial.

Authors:  Marcela González-Gross; Carlos Quesada-González; Javier Rueda; Manuel Sillero-Quintana; Nicolas Issaly; Angel Enrique Díaz; Eva Gesteiro; David Escobar-Toledo; Rafael Torres-Peralta; Marc Roller; Amelia Guadalupe-Grau
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.